Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Moleculin Biotech, Inc. from Q1 2019 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Moleculin Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q1 2019 to Q4 2024.
- Moleculin Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending December 31, 2024 was $141K, a 14% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)